Depression symptom profiles and long-term response to cognitive behavioral therapy plus contingency management for smoking cessation
Resumen: Background: Depression is heterogeneous in nature and using diagnostic categories limits insight into understanding psychopathology and its impact on treatment efficacy. This secondary analysis sought to: 1) identify distinct subpopulations of cigarette users with depression, and 2) examine their response to cognitive-behavioral treatment (CBT) + contingency management (CM) for smoking cessation at one year. Method: The sample comprised 238 (74 % females) adults who smoke receiving CBT only or CBT + CM. A latent class analysis was conducted on baseline depressive symptoms measured using the Beck Depression Inventory-II. Generalized estimating equations assessed the main and interactive effects of class, time, treatment, and sex on smoking abstinence. Results: Three distinct classes were identified: C1 (n= 76/238), characterized by mild depression, loss of energy, pessimism, and criticism, C2 (n= 100/238) presenting moderate severity and decreased appetite, and C3 (n= 62/238) showing severe depression, increased appetite, and feelings of punishment. There was a significant cluster × treatment interaction, which indicated additive effects of CM over CBT alone for Class 1 and 2. Persons in Class 1 and 2 were 3.60 [95 % CI: 1.62, 7.97] and 2.65 [95 % CI: 1.19, 5.91] times more likely to be abstinent if CBT + CM was delivered rather than CBT only. No differential sex effects were observed on treatment response according to cluster. Conclusions: Profiling depression symptom subtypes of cigarette users may be more informative to improve CM treatment response than merely focusing on total scores.
Idioma: Inglés
DOI: 10.1016/j.drugalcdep.2021.108808
Año: 2021
Publicado en: Drug and Alcohol Dependence 225 (2021), 108808 [7 pp.]
ISSN: 0376-8716

Factor impacto JCR: 4.852 (2021)
Categ. JCR: SUBSTANCE ABUSE rank: 8 / 37 = 0.216 (2021) - Q1 - T1
Categ. JCR: PSYCHIATRY rank: 44 / 143 = 0.308 (2021) - Q2 - T1
Categ. JCR: PSYCHIATRY rank: 61 / 155 = 0.394 (2021) - Q2 - T2
Categ. JCR: SUBSTANCE ABUSE rank: 6 / 21 = 0.286 (2021) - Q2 - T1

Factor impacto CITESCORE: 6.1 - Medicine (Q1) - Pharmacology, Toxicology and Pharmaceutics (Q2)

Factor impacto SCIMAGO: 1.438 - Pharmacology (Q1) - Toxicology (Q1) - Pharmacology (medical) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/MICINN/BES-2016-076663
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PSI2015-64371-P
Tipo y forma: Article (Published version)
Área (Departamento): Área Person.Eval.Trat.Psicoló. (Dpto. Psicología y Sociología)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2025-03-10-12:56:17)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Personalidad,Evaluación y Tratamiento Psicológicos



 Record created 2025-03-10, last modified 2025-03-10


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)